Abstract
To study the development of the atria, we produced a transgenic mouse line that expresses Cre under the regulatory control of a 7 kbp fragment of the Natriuretic peptide precursor type A gene (Nppa), from -3 kbp to +4 kbp relative to the transcription start site. Crossing this line with the R26R and Z/EG reporter lines revealed recombinase activity specifically in the cardiomyocytes of the atria and to a lesser extent the inflow tract from E10.5 onwards. At E14.5 recombination in the atria is almost complete. No recombination was observed outside the heart. These mice provide a tool to study gene function in the atria.
Copyright 2003 Wiley-Liss, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Atrial Natriuretic Factor
-
Cell Line
-
Genes, Reporter
-
Heart Atria / cytology*
-
Heart Atria / embryology
-
Heterozygote
-
Integrases / metabolism*
-
Mice
-
Mice, Transgenic
-
Microscopy, Fluorescence
-
Models, Genetic
-
Myocytes, Cardiac / enzymology*
-
Natriuretic Agents / chemistry
-
Natriuretic Peptide, C-Type / genetics*
-
Protein Precursors / genetics*
-
Recombination, Genetic
-
Time Factors
-
Viral Proteins / metabolism*
-
beta-Galactosidase / metabolism
Substances
-
Natriuretic Agents
-
Nppa protein, mouse
-
Protein Precursors
-
Viral Proteins
-
Natriuretic Peptide, C-Type
-
Atrial Natriuretic Factor
-
Cre recombinase
-
Integrases
-
beta-Galactosidase